Bio-Connect
Western blot analysis of HeLa cells using Nrf3 Polyclonal Antibody cells nucleus extracted by Minute™ Cytoplasmic and Nuclear Fractionation kit (SC-003, Inventbiotech, MN, USA).
Western blot analysis of HeLa cells using Nrf3 Polyclonal Antibody cells nucleus extracted by Minute™ Cytoplasmic and Nuclear Fractionation kit (SC-003, Inventbiotech, MN, USA).
Western blot analysis of HeLa cells using Nrf3 Polyclonal Antibody cells nucleus extracted by Minute™ Cytoplasmic and Nuclear Fractionation kit (SC-003, Inventbiotech, MN, USA).

Anti-Nrf3 NFE2L3 Antibody

A09888
Boster Bio
ApplicationsWestern Blot, ELISA
Product group Antibodies
ReactivityHuman, Mouse
TargetNFE2L3
100 ul
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Boster Bio
  • Product Name
    Anti-Nrf3 NFE2L3 Antibody
  • Delivery Days Customer
    9
  • Applications
    Western Blot, ELISA
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Gene ID9603
  • Target name
    NFE2L3
  • Target description
    NFE2 like bZIP transcription factor 3
  • Target synonyms
    NRF3, nuclear factor erythroid 2-related factor 3, NF-E2-related factor 3, NFE2-related factor 3, nuclear factor, erythroid 2 like 3, nuclear factor, erythroid derived 2, like 3, nuclear factor-erythroid 2 p45-related factor 3
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ9Y4A8
  • Protein Name
    Nuclear factor erythroid 2-related factor 3
  • Scientific Description
    Boster Bio Anti-Nrf3 NFE2L3 Antibody catalog # A09888. Tested in WB, ELISA applications. This antibody reacts with Human, Mouse.
  • Reactivity
    Human, Mouse
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Zhang L, Hu DL, Tang B, et al. NFE2L3 Inhibition Induces Cell Cycle Arrest at the G0/G1 Phase in Colorectal Cancer Cells through Downregulating CCND1 and pRb1-ser807/811. Dis Markers. 2019,2019:2829798. doi: 10.1155/2019/2829798
    Read this paper